5 completed, 1 unknown. 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 5, Unknown 1 |
Follow Graft Rejection: new trials by email Literature Review of Graft Rejection trials Research Report on Graft Rejection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation MabThera, Physiological serum (Sodium Chloride, sodium citrate) - Graft Rejection | Phase 3 | Unknown | University Hospital, Tours | 64 | 2008-10-01 | 2010-02-10 |
| Efficacy and Safety of Everolimus in Recipients of Heart Transplants to Prevent Acute and Chronic Rejection everolimus, mycophenolate mofetil, cyclosporine - Graft Rejection | Phase 3 | Completed | Novartis Pharmaceuticals | 721 | 2006-01-01 | 2012-08-16 |
| Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients Everolimus, Mycophenolic Acid (MPA), Cyclosporine A (CsA) - Kidney Transplantation, Graft Rejection | Phase 3 | Completed | Novartis | 833 | 2005-10-01 | 2011-05-10 |
| Safety/Efficacy of Everolimus and Neoral® in Adult Cardiac Transplant Patients With Established Allograft Vasculopathy everolimus - Graft Rejection | Phase 3 | Completed | Novartis Pharmaceuticals | 2004-08-01 | 2010-07-12 | |
| Study Comparing Conversion From Calcineurin Inhibitors to Rapamune Versus Standard Therapy in Established Renal Allograft Recipients Cyclosporin or tacrolimus - Graft Rejection, Kidney Failure | Phase 3 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 190 | 2002-01-01 | 2011-03-08 |
| Collaborative Corneal Transplantation Studies (CCTS) Histocompatibility Matching - Corneal Transplantation, Graft Rejection | Phase 3 | Completed | National Eye Institute (NEI) | 1986-05-01 | 2009-09-17 |
Heart Diseases (1) · Renal Insufficiency (1)
Cardiovascular Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Cyclosporine (3) · Everolimus (3) · Adrenal Cortex Hormones (2) · Mycophenolic Acid (2) · Basiliximab (1) · Rituximab (1) · Sodium Chloride (1) · Sodium Citrate (1) · Tacrolimus (1)
Novartis Pharmaceuticals (2) · National Eye Institute (NEI) (1) · Novartis (1) · University Hospital, Tours (1) · Wyeth is now a wholly owned subsidiary of Pfizer (1)
United States (3) · France (2) · Argentina (1) · Australia (1) · Austria (1) · Belgium (1) · Canada (1) · Germany (1) · Italy (1) · New Zealand (1) · Norway (1) · Puerto Rico (1) · Spain (1) · Taiwan (1) · United Kingdom (1)